Question 1

Does BlackRock own ACAD stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BlackRock holds 22,515,173 shares of ACAD (Acadia Pharmaceuticals), worth $569.6M.

Question 2

How many shares of ACAD does BlackRock own?

Accepted Answer

As of its Q2 2026 13F, BlackRock holds 22,515,173 shares of ACAD (Acadia Pharmaceuticals).

Question 3

What is BlackRock's ACAD position worth?

Accepted Answer

As of its Q2 2026 13F, BlackRock's ACAD position is worth $569.6M.

Question 4

Is BlackRock buying or selling ACAD?

Accepted Answer

In Q2 2026, BlackRock increased its ACAD position by 964,252 shares (+4.5%).

Question 5

When did BlackRock first buy ACAD?

Accepted Answer

BlackRock already held ACAD in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	22.5M	+4.5%	$569.6M	0.0%	$25.30	33
2026-Q1	Increased	21.6M	+3.8%	$479.7M	0.0%	$22.26	33
2025-Q4	Increased	20.8M	+2.4%	$554.4M	0.0%	$26.71	32
2025-Q3	Decreased	20.3M	-1.9%	$432.5M	0.0%	$21.34	0
2025-Q2	Decreased	20.7M	-3.3%	$445.5M	0.0%	$21.57	0
2025-Q1	Increased	21.4M	+67.8%	$354.9M	0.0%	$16.61	46
2024-Q4	Decreased	12.7M	-0.5%	$233.6M	0.0%	$18.35	0
2024-Q3	First report	12.8M	-	$196.8M	0.0%	$15.38	0

ACAD8 quarters

ACAD
8 quarters